品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
Trinan | KFG35B09-100mg | 100mg | 现货 | 123318-82-1 |
(2R,3R,4S,5R)-5-(6-氨基-2-氯-9H... (2R,3R,4S,5R)-5-(6-Amino-2-c... |
97% |
|
|
Trinan | KFG35B09-25mg | 25mg | 现货 | 123318-82-1 |
(2R,3R,4S,5R)-5-(6-氨基-2-氯-9H... Clofarabine |
97% |
|
|
Trinan | KFG35B09-5mg | 5mg | 现货 | 123318-82-1 |
(2R,3R,4S,5R)-5-(6-氨基-2-氯-9H... Clofarabine |
97% |
|
|
Trinan | KFG35B09-1g | 1g | 现货 | 123318-82-1 |
(2R,3R,4S,5R)-5-(6-氨基-2-氯-9H... (2R,3R,4S,5R)-5-(6-Amino-2-c... |
97% |
|
|
Trinan | KFG35B09-250mg | 250mg | 现货 | 123318-82-1 |
(2R,3R,4S,5R)-5-(6-氨基-2-氯-9H... (2R,3R,4S,5R)-5-(6-Amino-2-c... |
97% |
|
|
毕佳索 | BJS3889697-0.1g | 0.1g | 现货 | 123318-82-1 |
(2R,3R,4S,5R)-5-(6-氨基-2-氯-9H... (2R,3R,4S,5R)-5-(6-Amino-2-c... |
97% |
|
|
毕佳索 | BJS3889697-1g | 1g | 现货 | 123318-82-1 |
克罗拉滨 Clofarabine |
97% |
|
|
毕佳索 | BJS3889697-0.25g | 0.25g | 现货 | 123318-82-1 |
(2R,3R,4S,5R)-5-(6-氨基-2-氯-9H... (2R,3R,4S,5R)-5-(6-Amino-2-c... |
97% |
|
|
毕佳索 | BJS3889697-0.025g | 0.025g | 现货 | 123318-82-1 |
(2R,3R,4S,5R)-5-(6-氨基-2-氯-9H... (2R,3R,4S,5R)-5-(6-Amino-2-c... |
97% |
|
|
毕佳索 | BJS3889697-0.005g | 0.005g | 现货 | 123318-82-1 |
(2R,3R,4S,5R)-5-(6-氨基-2-氯-9H... (2R,3R,4S,5R)-5-(6-Amino-2-c... |
97% |
|
|
毕佳索 | BJS3889697-100mg | 100mg | 现货 | 123318-82-1 |
克罗拉滨 Clofarabine |
97% |
|
|
毕佳索 | BJS3889697-250mg | 250mg | 现货 | 123318-82-1 |
克罗拉滨 Clofarabine |
97% |
|
|
Trinan | BJS3889697-100mg | 100mg | 现货 | 123318-82-1 |
克罗拉滨 Clofarabine |
97% |
|
|
Trinan | BJS3889697-250mg | 250mg | 现货 | 123318-82-1 |
克罗拉滨 Clofarabine |
97% |
|
|
Trinan | BJS3889697-1g | 1g | 现货 | 123318-82-1 |
克罗拉滨 Clofarabine |
97% |
|
|
普西唐 | C10813-100mg | 100mg | 现货 | 123318-82-1 |
氯法拉滨 Clofarabine |
≥98% |
|
|
普西唐 | C10813-250mg | 250mg | 现货 | 123318-82-1 |
氯法拉滨 Clofarabine |
≥98% |
|
|
普西唐 | C10813-1g | 1g | 现货 | 123318-82-1 |
氯法拉滨 Clofarabine |
≥98% |
|
|
麦克林 | C804391-5mg | 5mg | 现货 | 123318-82-1 |
克罗拉滨 Clofarabine |
99% |
|
|
麦克林 | C804391-25mg | 25mg | 现货 | 123318-82-1 |
克罗拉滨 Clofarabine |
99% |
|
|